Literature DB >> 33226880

Plasma albumin and calcium concentrations, and long-term mortality in primary health care patients in Sweden.

Sofia Dalemo1,2, Kristina Bengtsson Boström1,2, Per Hjerpe1,2.   

Abstract

OBJECTIVE: Low plasma (p)-albumin and p-calcium concentrations are associated with increased mortality in hospitalised patients. There are few studies addressing this in primary care. Low p-calcium has been associated with mortality, but it is not known whether this applies to p-albumin. Could p-albumin and p-calcium be used as markers of an increased risk of mortality?
PURPOSE: To study p-albumin and p-calcium at baseline and their association with mortality after 10-14 years.
DESIGN: Prospective cohort study using data from a large primary health care area and the National Swedish Cause of Death Register.
SETTING: Primary health care in Skaraborg, Sweden.
SUBJECTS: 43,052 patients (39.1% men), ≥18 years, 60.7 ± 18.4 years with p-albumin and p-calcium concentrations registered in 2001-2005. MAIN OUTCOME MEASURES: P-albumin and p-calcium concentrations at baseline and their association with mortality after a mean follow-up period of 10.3 ± 4.0 years.
RESULTS: Low p-albumin was associated with total mortality compared with normal p-albumin, greatest at lower ages (18-47 years). The hazard ratios for women and men were 3.12 (95% CI 1.27-7.70) and 4.09 (95% CI 1.50-11.14), respectively. The increased mortality was seen in both cardiovascular and malignant diseases in both women and men. In contrast, low p-calcium was not associated with increased mortality, 1.00 (95% CI 0.96-1.05). Elevated p-calcium was associated with increased mortality, 1.17 (95% CI 1.13-1.22).
CONCLUSIONS: Low p-albumin could be a marker of an increased risk of mortality, especially in patients of younger ages. This finding should prompt diagnostic measures in order to identify underlying causes. KEY POINTS Low p-albumin and calcium concentrations have been associated with increased mortality in hospitalised patients, but this is unexplored in primary care patients. A low p-albumin concentration at baseline was a risk marker for mortality; highest in the younger age groups. Increased mortality in both cardiovascular and malignant diseases was seen in both men and women with low compared with normal p-albumin concentrations. Elevated but not low p-calcium concentrations were associated with increased mortality after 10-14 years of follow-up.

Entities:  

Keywords:  Age groups; albumin; hypoalbuminemia; hypocalcemia; mortality; primary healthcare

Mesh:

Substances:

Year:  2020        PMID: 33226880      PMCID: PMC7783069          DOI: 10.1080/02813432.2020.1843809

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  27 in total

Review 1.  Causes and mechanisms of hypoalbuminaemia.

Authors:  P E Ballmer
Journal:  Clin Nutr       Date:  2001-06       Impact factor: 7.324

2.  Laboratory reference intervals during pregnancy, delivery and the early postpartum period.

Authors:  Anna Klajnbard; Pal B Szecsi; Nina P Colov; Malene R Andersen; Maja Jørgensen; Brian Bjørngaard; Anne Barfoed; Katrine Haahr; Steen Stender
Journal:  Clin Chem Lab Med       Date:  2010-02       Impact factor: 3.694

3.  Serum albumin and mortality.

Authors: 
Journal:  Lancet       Date:  1990-02-10       Impact factor: 79.321

4.  Diagnosis of patients with raised serum calcium level in primary care, Sweden.

Authors:  Sofia Dalemo; Per Hjerpe; Kristina Boström Bengtsson
Journal:  Scand J Prim Health Care       Date:  2006-09       Impact factor: 2.581

Review 5.  Hypoalbuminemia.

Authors:  Angelo Gatta; Alberto Verardo; Massimo Bolognesi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

6.  Serum albumin level and physical disability as predictors of mortality in older persons.

Authors:  M C Corti; J M Guralnik; M E Salive; J D Sorkin
Journal:  JAMA       Date:  1994-10-05       Impact factor: 56.272

7.  Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995.

Authors:  Lars Age Johansson; Charlotte Björkenstam; Ragnar Westerling
Journal:  J Clin Epidemiol       Date:  2009-04-11       Impact factor: 6.437

8.  Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-old.

Authors:  Sven Streit; Jacobijn Gussekloo; Robert A Burman; Claire Collins; Biljana Gerasimovska Kitanovska; Sandra Gintere; Raquel Gómez Bravo; Kathryn Hoffmann; Claudia Iftode; Kasper L Johansen; Ngaire Kerse; Tuomas H Koskela; Sanda Kreitmayer Peštić; Donata Kurpas; Christian D Mallen; Hubert Maisonneuve; Christoph Merlo; Yolanda Mueller; Christiane Muth; Rafael H Ornelas; Marija Petek Šter; Ferdinando Petrazzuoli; Thomas Rosemann; Martin Sattler; Zuzana Švadlenková; Athina Tatsioni; Hans Thulesius; Victoria Tkachenko; Peter Torzsa; Rosy Tsopra; Canan Tuz; Marjolein Verschoor; Rita P A Viegas; Shlomo Vinker; Margot W M de Waal; Andreas Zeller; Nicolas Rodondi; Rosalinde K E Poortvliet
Journal:  Scand J Prim Health Care       Date:  2018-01-25       Impact factor: 2.581

9.  Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients.

Authors:  Cyril Mousseaux; Axelle Dupont; Cédric Rafat; Kenneth Ekpe; Etienne Ghrenassia; Lionel Kerhuel; Fanny Ardisson; Eric Mariotte; Virginie Lemiale; Benoît Schlemmer; Elie Azoulay; Lara Zafrani
Journal:  Ann Intensive Care       Date:  2019-11-27       Impact factor: 6.925

10.  Derivation and internal validation of an equation for albumin-adjusted calcium.

Authors:  Matthew T James; Jianguo Zhang; Andrew W Lyon; Brenda R Hemmelgarn
Journal:  BMC Clin Pathol       Date:  2008-11-27
View more
  1 in total

1.  Albumins as Extracellular Protein Nanoparticles Collaborate with Plasma Ions to Control Biological Osmotic Pressure.

Authors:  Zihui Zheng; Yuanyuan Wang; Meng Li; Dongfang Li; Aobo Nie; Miao Chen; Qinli Ruan; Yichen Guo; Jun Guo
Journal:  Int J Nanomedicine       Date:  2022-10-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.